These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7901705)

  • 1. HLA-DP class II antigens in transfusion-associated graft versus host disease.
    Nagumo F; Sano M; Tadano J; Katano M; Kubota E; Kikuchi M; Nose Y
    Lancet; 1993 Dec; 342(8884):1424. PubMed ID: 7901705
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
    Petersdorf EW; Smith AG; Mickelson EM; Longton GM; Anasetti C; Choo SY; Martin PJ; Hansen JA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1230-1. PubMed ID: 8442097
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
    Kato Y; Mitsuishi Y; Cecka M; Hopfield J; Hunt L; Champlin R; Terasaki PI; Gajewski JL
    Transplantation; 1991 Aug; 52(2):374-6. PubMed ID: 1871811
    [No Abstract]   [Full Text] [Related]  

  • 4. Nomenclature for factors of the HLA system, update November/December 1997.
    Marsh SG
    Tissue Antigens; 1998 Mar; 51(3):317. PubMed ID: 9550337
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of association between the frequencies of HLA-DR or HLA-DP alleles and the occurrence of chronic graft-versus-host disease.
    Pawelec G; Müller C; Haen M; Schaudt K; Ehninger G
    Transplantation; 1991 Apr; 51(4):917-8. PubMed ID: 2014555
    [No Abstract]   [Full Text] [Related]  

  • 6. Nomenclature for factors of the HLA system, update November/December 1997. WHO Nomenclature Committee for Factors of the HLA System.
    Marsh SG
    Hum Immunol; 1998 Feb; 59(2):135. PubMed ID: 9536437
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
    Rutten CE; van Luxemburg-Heijs SA; Griffioen M; Marijt EW; Jedema I; Heemskerk MH; Posthuma EF; Willemze R; Falkenburg JH
    Leukemia; 2008 Jul; 22(7):1387-94. PubMed ID: 18418406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DPB1 mismatch and acute graft-versus host disease in HLA-identical sibling donors.
    Mosaad YM; Kamel H
    Egypt J Immunol; 2005; 12(2):21-8. PubMed ID: 17977207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DP genotyping in HLA-A,B, and DR identical intrafamilial bone marrow transplantation.
    al-Daccak R; Loiseau P; Soulie A; Varrin F; Rabian C; Raffoux C; Cohen D; Degos L; Gluckman E; Colombani J
    Leukemia; 1990 Mar; 4(3):222-6. PubMed ID: 1969010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RFLP analysis with cDNA probes for DQ/DP region in HLA identical sibling marrow transplants: lack of correlation with GvHD.
    Gaozza E; Piccoli P; Ferrara GB; Bacigalupo A
    Haematologica; 1991; 76(1):8-13. PubMed ID: 1676012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permissive, nonpermissive HLA-DPB1 epitope disparities and the specificity of T cells infiltrating the skin during acute graft-versus-host disease.
    Vié H; Gaschet J; Milpied N
    Blood; 2011 May; 117(21):5779-81. PubMed ID: 21617014
    [No Abstract]   [Full Text] [Related]  

  • 12. Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants.
    Middleton D; Mytilineos Y; Savage D; Ferrara GB; Angelini G; Amoroso A; Trainor F; Gaweco A; Mazzola G; Delfino L
    Transplant Proc; 1992 Dec; 24(6):2439-40. PubMed ID: 1361255
    [No Abstract]   [Full Text] [Related]  

  • 13. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.
    Fontenot AP; Torres M; Marshall WH; Newman LS; Kotzin BL
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12717-22. PubMed ID: 11050177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.
    Gaschet J; Lim A; Liem L; Vivien R; Hallet MM; Harousseau JL; Even J; Goulmy E; Bonneville M; Milpied N; Vié H
    J Clin Invest; 1996 Jul; 98(1):100-7. PubMed ID: 8690780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DPA1 and HLA-DPB1 in rheumatoid arthritis and its subsets.
    Hutchings CJ; Hillarby MC; McMahon MJ; Ollier WE; Grennan DM
    Dis Markers; 1993 Jun; 11(1):37-44. PubMed ID: 8358964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.
    Rutten CE; van Luxemburg-Heijs SA; Halkes CJ; van Bergen CA; Marijt EW; Oudshoorn M; Griffioen M; Falkenburg JH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):40-8. PubMed ID: 22871556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomenclature for factors of the HLA system, update November 2017.
    Marsh SGE
    Int J Immunogenet; 2018 Apr; 45(2):75-87. PubMed ID: 29417746
    [No Abstract]   [Full Text] [Related]  

  • 18. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomenclature for factors of the HLA system, update December 2017.
    Marsh SGE
    Int J Immunogenet; 2018 Apr; 45(2):88-93. PubMed ID: 29405566
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemia.
    Munro LR; Culligan DJ; Grant A; Johnston PW; Watson HG
    Vox Sang; 2002 Oct; 83(3):279-81. PubMed ID: 12366774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.